• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Exits

Turkven completes Medical Park listing on Borsa Istanbul

  • Nicole Tovstiga
  • Nicole Tovstiga
  • 08 February 2018
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Turkish GP Turkven has listed hospital group Medical Park on the Borsa Istanbul with a $1.02bn market cap.

The Turkey-headquartered GP made a full exit selling 72.8 million shares, including overallotment against demand for 89.2 million shares.

The offering was set at 19 lira per share, after initially being priced at up to 28.8 lira. Following low demand and sharp drops on global stock markets, the IPO price range was revised down to 19-20 lira.

Medical Park

  • DEAL:

    Exit

  • VALUE:

    $1.02bn

  • LOCATION:

    Istanbul

  • SECTOR:

    Healthcare providers

  • FOUNDED:

    2005

  • STAFF:

    15,000

  • VENDOR:

    Turkven

  • RETURNS:

    $370m

Together with the capital raise, the company netted TRY 600m in gross proceeds through the listing. These would be used to reduce net debt by repaying foreign-currency-denominated debt arising from the company's syndicated loan facilities, according to the firm.

Sold shares represented 36.15% of Medical Park's total capital, earning the seller around TRY 1.38bn ($370m) out of a total valuation of TRY 3.83bn ($1.02bn).

Of the sold shares, 83.5% of the offered shares sold to a total of 30 international institutional investors, and the remainder was sold to 69 domestic institutional investors and a further 5,252 individual investors.

Temasek bought 9.95 million shares (15.7%), Genesis Investment 7.36 million (11.6%), Charlemagne Capital 6.5 million shares (10.3%), Carrhae Capital 5.25 million (8.3%), AllianceBernstein 4.42 million (7%), Goldman Sachs 3.68 million (5.8%), and East Capital 3.38 million (5.3%).

Trading will commence on 13 February. AK Investment acted as bookrunner for the offering.

Previous funding
Carlyle initially invested in the hospital group in December 2009, picking up a 40% stake in an all-equity deal via its MENA fund. In January 2014, Turkven acquired Carlyle's 40% holding. The deal saw the company's other investors, Sancak Group and Usta Group, also partially sell their interests.

Unquote reported Turkven's intentions to float Medical Park in August 2017, marking the end of the GP's ownership after a three-year holding. 

Company
Medical Park was established in 2005 through a partnership between two existing hospitals based in Istanbul. It operates with 1,750 physicians, 15,000 employees and 4,900 beds across 29 hospitals.

People
Turkven – Seymur Tari (founder, CEO).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Exits
  • CEE
  • Healthcare
  • Turkey
  • Turkven Private Equity
  • IPO

More on Exits

Public sector software
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • Exits
  • 04 September 2023
Lender taking the keys from a sponsor
Ares Management handed keys to two-thirds of UK sponsor’s portfolio

Lender provided GBP 500m for three of the GP's deals between 2016 and 2019, Debtwire reported

  • Financing
  • 30 August 2023
Luggage and airport services
Actera Group explores strategic options for Celebi Ground Handling

Several investors placed bids for the company in 2022 but mismatch in pricing didn't lead to a deal

  • Exits
  • 30 August 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013